A National Registry for Healthy Volunteers in Phase 1 Clinical Trials

被引：31
|
作者：
Resnik, David B. [1 ]
Koski, Greg [2 ,3 ]
机构：
[1] NIEHS, NIH, Res Triangle Pk, NC 27709 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Mongan Inst Hlth Policy, Boston, MA USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 12期
关键词：
D O I：
10.1001/jama.2011.354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1236 / 1237
页数：2
相关论文
共 50 条
  • [31] SENSATION SEEKING AMONGST HEALTHY-VOLUNTEERS PARTICIPATING IN PHASE-I CLINICAL-TRIALS
    FARRE, M
    LAMAS, X
    CAMI, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) : 405 - 409
  • [32] Clinical development of new drugs. Safety of clinical trials in healthy volunteers
    Dal-Re, Rafael
    MEDICINA CLINICA, 2016, 147 (04): : 154 - 156
  • [33] Serious adverse events in healthy volunteers identified during clinical trials
    Coimbra Hurtado, Jimena
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 48 - 48
  • [34] A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials
    Young, Tina C.
    Srinivasan, Subasree
    Vetter, Marion L.
    Sethuraman, Venkat
    Bhagwagar, Zubin
    Zwirtes, Ricardo
    Narasimhan, Premkumar
    Chuang, Tilda
    Smyth, Brendan J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1079 - 1087
  • [35] Arrhythmias Seen in Baseline 24-Hour Holter ECG Recordings in Healthy Normal Volunteers During Phase 1 Clinical Trials
    Hingorani, Pooja
    Karnad, Dilip R.
    Rohekar, Prashant
    Kerkar, Vaibhav
    Lokhandwala, Yash Y.
    Kothari, Snehal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (07): : 885 - 893
  • [36] Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during Phase 1 clinical trials
    Cantilena, Louis R.
    Cherstniakova, Svetlana A.
    Saviolakis, George
    Kahn, Roberta
    Elkashef, Ahmed
    Rose, Lauren
    Vocci, Frank
    CONTEMPORARY CLINICAL TRIALS, 2007, 28 (06) : 695 - 704
  • [37] Severe neutropenia among healthy volunteers given rifabutin in clinical trials
    Flexner, C
    Barditch-Crovo, PA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (06) : 592 - 593
  • [38] Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Swezey, Teresa
    Fisher, Jill A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 : S30 - S36
  • [39] Should healthy volunteers in clinical trials be paid according to risk? Yes
    Jones, Eleri
    Liddell, Kathleen
    BRITISH MEDICAL JOURNAL, 2009, 339 : b4142
  • [40] Healthy Volunteers for Clinical Trials in Resource-Poor Settings: National Registries Can Address Ethical and Safety Concerns
    Bompart, Francois
    CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2019, 28 (01) : 134 - 143
12345